Listed

Kraig Biocraft Laboratories, Inc.: Form 10-Q for the period ended Sep 30, 2017

Filed with the SEC on Nov 15, 2017 and accepted by EDGAR at Nov 15, 2017, 16:08 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2017-07-01 to 2017-09-30$25.4kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2017-01-01 to 2017-09-30$191.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2017-07-01 to 2017-09-30−$234.4kus-gaap:OperatingIncomeLoss
Operating income9 months2017-01-01 to 2017-09-30−$1.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-07-01 to 2017-09-30$45.4kus-gaap:InterestExpense
Interest expense9 months2017-01-01 to 2017-09-30$129.3kus-gaap:InterestExpense
Income tax3 months2017-07-01 to 2017-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2017-01-01 to 2017-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-07-01 to 2017-09-30−$279.8kus-gaap:NetIncomeLoss
Net income9 months2017-01-01 to 2017-09-30−$2.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-07-01 to 2017-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2017-01-01 to 2017-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2017-01-01 to 2017-09-30−$650.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2017-01-01 to 2017-09-30$24.2kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-09-30$74.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-09-30$108.4kus-gaap:AssetsCurrent
Total assetsAt period end2017-09-30$170.1kus-gaap:Assets
Current liabilitiesAt period end2017-09-30$3.2mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2017-09-30−$3.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001654954-17-010747. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.